Facing this heterogeneous expression in bladder tumors, we performed further real-time PCR expression analysis using eight patient-matched specimens including NU, CIS, and invasive tumor tissues from each single patient allowing a precise assessment of ST6GAL1 mRNA expression in the course of bladder cancer progression (Figure 1D). The gene discussed is ST6GAL1; the disease is urinary bladder carcinoma.